首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Long-term follow-up of the Hemodialysis Infection Prevention with Polysporin Ointment (HIPPO) Study: a quality improvement report.
【24h】

Long-term follow-up of the Hemodialysis Infection Prevention with Polysporin Ointment (HIPPO) Study: a quality improvement report.

机译:多孢菌素软膏预防血液透析感染的长期随访(HIPPO)研究:质量改善报告。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Infection is a common and serious complication in hemodialysis patients accessed using central venous catheters (CVCs). Previously, a randomized double-blinded trial (HIPPO [Hemodialysis Infection Prevention With Polysporin Ointment] Study) showed that application of a topical polyantibiotic ointment at the CVC exit site decreased CVC-related infections, including bacteremias and their adverse consequences. Based on this study's results, our institution implemented a policy of routine topical polyantibiotic ointment application for CVC-related infection prophylaxis. The main purpose of this prospective observational study was to determine whether the low rate of CVC-related infection achieved by topical polyantibiotic ointment use during a randomized controlled trial would be observed during long-term prophylaxis as part of routine clinical care. STUDY DESIGN: Quality improvement report. SETTING & PARTICIPANTS: All adult long-term hemodialysis patients using a tunneled cuffed CVC in a large university-affiliated outpatient hemodialysis program in 2004-2009 were included. QUALITY IMPROVEMENT PLAN: To prospectively monitor the impact of a policy-wide strategy of topical polyantibiotic ointment application at CVC exit sites (1 time/wk) as infection prophylaxis. A multidisciplinary team approach to the surveillance, prospective tracking, and management of hemodialysis CVC-related infection was used. OUTCOMES & MEASUREMENTS: Rates of CVC-related infections (exit-site infections and bacteremias), percentages of contributing organisms, and consequences of CVC-related infections. RESULTS: After 6 years, CVC exit-site infection and bacteremia rates remained low (<1.0/1,000 catheter-days). Gram-positive organisms accounted for 61.2% of exit-site infections and 72.1% of bacteremias. LIMITATIONS: A center effect of the same institution conducting the randomized trial and the quality improvement study may limit the study's generalizability to other centers. The impact of possible unmeasured cointerventions cannot be excluded. CONCLUSION: Long-term use of topical antibiotic application at CVC exit sites resulted in a sustained decrease in all CVC-related infections. A multidisciplinary effort to monitor and track outcomes allowed safe and effective implementation of a new prophylactic strategy.
机译:背景:在使用中央静脉导管(CVC)进行血液透析的患者中,感染是常见且严重的并发症。以前,一项随机双盲试验(HIPPO [用多孢菌素软膏预防血液透析感染]研究)显示,在CVC出口部位使用局部抗生素抗生素软膏可减少与CVC相关的感染,包括菌血症及其不良后果。根据这项研究的结果,我们机构实施了常规局部应用多抗生素软膏来预防CVC相关感染的政策。这项前瞻性观察性研究的主要目的是确定在长期预防期间作为常规临床护理的一部分,是否可以观察到在随机对照试验中局部使用多抗生素软膏达到的低CVC相关感染率。研究设计:质量改进报告。地点与参与者:纳入了2004-2009年在大学附属的大型门诊血液透析计划中使用隧道式袖带CVC的所有成人长期血液透析患者。质量改进计划:为了预防感染,前瞻性地监测了在CVC出口部位局部应用多抗生素软膏(1次/周)的政策范围策略的影响。使用了多学科团队的方法来监视,前瞻性跟踪和管理血液透析CVC相关感染。结果与测量:与CVC相关的感染(出院感染和菌血症)的发生率,贡献菌的百分比以及与CVC相关的感染的后果。结果:6年后,CVC出口部位感染和菌血症发生率仍然较低(<1.0 / 1,000导管天)。革兰氏阳性菌占出口部位感染的61.2%,菌血症占72.1%。局限性:同一机构进行随机试验和质量改善研究的中心效应可能会限制该研究对其他中心的推广。不能排除可能的无法衡量的共同干预的影响。结论:在CVC出口部位长期使用局部抗生素可导致所有CVC相关感染持续减少。监视和跟踪结果的多学科努力允许安全有效地实施新的预防策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号